Cargando…
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)
PURPOSE: We investigated the efficacy of temozolomide during and after radiotherapy in Korean adults with anaplastic gliomas without 1p/19q co-deletion. MATERIALS AND METHODS: This was a randomized, open-label, phase 2 study and notably the first multicenter trial for Korean grade III glioma patient...
Autores principales: | Hwang, Kihwan, Kim, Tae Min, Park, Chul-Kee, Chang, Jong Hee, Jung, Tae-Young, Kim, Jin Hee, Nam, Do-Hyun, Kim, Se-Hyuk, Yoo, Heon, Hong, Yong-Kil, Kim, Eun-Young, Lee, Dong-Eun, Joo, Jungnam, Kim, Yu Jung, Choe, Gheeyoung, Choi, Byung Se, Kang, Seok-Gu, Kim, Jeong Hoon, Kim, Chae-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176949/ https://www.ncbi.nlm.nih.gov/pubmed/31671938 http://dx.doi.org/10.4143/crt.2019.421 |
Ejemplares similares
-
Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)
por: Ahn, Grace S., et al.
Publicado: (2022) -
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)
por: Yoon, Wan-Soo, et al.
Publicado: (2023) -
Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open‐label phase 2 study
por: Hwang, Kihwan, et al.
Publicado: (2021) -
Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017) -
Fourth Ventricle Neurenteric Cyst Mimicking Hemangioblastoma
por: Choe, Eugenie, et al.
Publicado: (2017)